Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FMC CORP Investor Presentation 2003

Sep 19, 2003

31144_rns_2003-09-19_2391f775-9021-4d40-a67b-cdfb2c8aca38.zip

Investor Presentation

Open in viewer

Opens in your device viewer

8-K 1 d8k.htm FORM 8-K Form 8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

September 18, 2003

FMC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware 1-2376 94-0479804
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

1735 Market Street, Philadelphia, PA 19103

(Address of principal executive offices) (Zip Code)

(215) 299-6000

Registrant’s telephone number, including area code

ITEM 9. Regulation FD Disclosure.

Investor information meetings were held at the Credit Suisse First Boston Annual Chemical Conference on September 18, 2003. Slides used in the presentation at the meetings by William G. Walter, President and Chief Executive Officer, are attached hereto as an exhibit to this report. These slides may also be accessed at the company’s website ( www.fmc.com ), and will be available for a period of at least thirty days.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FMC C ORPORATION
By /s/ W. K IM F OSTER
W. Kim Foster Senior Vice President and Chief Financial Officer

Date: September 19, 2003

EXHIBIT INDEX

Exhibit Number Description
99.1 FMC Overview by William G. Walter at Credit Suisse First Boston Chemical Conference, September 18, 2003.